https://www.orthoworld.com
ORTHOWORLD
Orthobiologics Strategy: FDA Issues New Warning about Sales of Unapproved Products
By Scott Bruder

FDA doubled down on its enforcement commitment for Human Cell and Tissue Products after its enforcement discretion ended in May.